<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) accounts for 80% of Non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in Uganda </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> is fast growing with a very short doubling time </plain></SENT>
<SENT sid="2" pm="."><plain>Inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, achieved through the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inhibitor family of proteins enhances survival of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to explore the expression of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> related proteins Survivin, Livin and Thrombospondin-1 (TSP-1) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and comparing it with the expression in reactive <z:hpo ids='HP_0002729'>follicular hyperplasia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Among the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cases, survivin was positive in 37 (75%) and negative in 12 (25%) </plain></SENT>
<SENT sid="5" pm="."><plain>Livin staining was positive in 23 (48%) and negative in 25 (52%) of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cases </plain></SENT>
<SENT sid="6" pm="."><plain>TSP-1 was positive in 40 (87%) and negative in 6 (13%) of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cases </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the 10 reactive <z:mp ids='MP_0000688'>lymphoid hyperplasia</z:mp> (RLH) were positive for survivin, livin expression was found in 4 (40%), whereas TSP-1 was positive in 7 (70%) of the RLH cases </plain></SENT>
<SENT sid="8" pm="."><plain>Among the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, there was no statistically significant association between survivin and livin expression (p = 0.6), livin and TSP-1 (p = 1.0) or survivin and TSP-1 (p = 0.6) </plain></SENT>
<SENT sid="9" pm="."><plain>Likewise no statistical association was found between the expressions of the proteins in RLH </plain></SENT>
<SENT sid="10" pm="."><plain>There was no statistically significant difference between the expression frequency of the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> associated proteins examined in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and RLH </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, we have demonstrated the expression of inhibitor of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> proteins, survivin and Livin and the pro-apoptotic protein TSP-1 in endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>No significant difference was found between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and RLH </plain></SENT>
</text></document>